Login / Signup
A pre-specified analysis of the SELECT trial suggests a kidney benefit of semaglutide in patients without diabetes.
Ellen F Carney
Published in:
Nature reviews. Nephrology (2024)
Keyphrases
</>
end stage renal disease
type diabetes
ejection fraction
newly diagnosed
clinical trial
peritoneal dialysis
prognostic factors
study protocol
randomized controlled trial
metabolic syndrome
patient reported outcomes
adipose tissue
insulin resistance